Canaccord Genuity upgraded shares of Canopy Growth (TSE:WEED) from a hold rating to a speculative buy rating in a report issued on Thursday morning. They currently have C$50.00 price objective on the stock, up from their previous price objective of C$34.00.

WEED has been the topic of several other research reports. Eight Capital lifted their target price on shares of Canopy Growth from C$40.00 to C$50.00 in a research report on Friday, July 6th. Cormark lifted their target price on shares of Canopy Growth from C$25.00 to C$33.00 in a research report on Thursday, June 28th.

WEED stock traded up C$2.94 during mid-day trading on Thursday, reaching C$43.62. 5,455,756 shares of the company traded hands, compared to its average volume of 5,683,650. Canopy Growth has a fifty-two week low of C$8.36 and a fifty-two week high of C$48.72.

About Canopy Growth

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names.

Featured Article: Google Finance

Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with's FREE daily email newsletter.